Schiller P W, Nguyen T M, Weltrowska G, Wilkes B C, Marsden B J, Lemieux C, Chung N N
Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal, PQ, Canada.
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11871-5. doi: 10.1073/pnas.89.24.11871.
Opioid peptide analogs consisting entirely of aromatic amino acid residues and containing conformationally restricted phenylalanine derivatives in position 2 of the peptide sequence were synthesized and pharmacologically characterized in vitro. Both diastereoisomers of H-Tyr-(D or L)-NMePhe-Phe-Phe-NH2 (NMePhe is N alpha-methylphenylalanine) were mu-receptor-selective, were full agonists in the mu-receptor-representative guinea pig ileum assay, and were partial agonists in the mouse vas deferens assay, with the L-NMePhe2 analog displaying somewhat higher intrinsic activity than the D-NMePhe2 analog. Further conformational restriction at position 2 in the sequence, as achieved through substitution of D- or L-tetrahydro-3-isoquinoline carboxylic acid (Tic), produced a configuration-dependent differential effect on receptor selectivity and intrinsic activity, leading to a potent mu-selective mu agonist (the D-Tic2 analog) with increased intrinsic activity in the mouse vas deferens assay and to a potent delta-selective delta antagonist (the L-Tic2 analog). These results demonstrate that imposition of conformational constraints in a peptide not only may alter receptor selectivity but also may decrease, totally abolish, or even enhance intrinsic activity. The tetrapeptide H-Tyr-Tic-Phe-Phe-NH2 was a moderately potent full agonist in the guinea pig ileum assay and, thus, represents a compound with mixed mu-agonist/delta-antagonist properties. The corresponding peptide with a free C-terminal carboxyl group H-Tyr-Tic-Phe-Phe-OH showed high delta-receptor affinity (Ki delta = 1.2 nM), unprecedented delta selectivity (Ki mu/Ki delta = 1410), high potency as delta antagonist (Ke = 3-8 nM against various delta agonists in the mouse vas deferens assay) and, unlike other delta antagonists, had no mu-antagonist properties. The tripeptides H-Tyr-Tic-Phe-OH and H-Tyr-Tic-Phe-NH2 were also delta antagonists.
合成了完全由芳香族氨基酸残基组成且在肽序列第2位含有构象受限苯丙氨酸衍生物的阿片样肽类似物,并对其进行了体外药理学表征。H-Tyr-(D或L)-NMePhe-Phe-Phe-NH2(NMePhe为Nα-甲基苯丙氨酸)的两种非对映异构体均对μ受体具有选择性,在μ受体代表性的豚鼠回肠试验中为完全激动剂,在小鼠输精管试验中为部分激动剂,L-NMePhe2类似物的内在活性略高于D-NMePhe2类似物。通过取代D-或L-四氢-3-异喹啉羧酸(Tic)在序列第2位进一步限制构象,对受体选择性和内在活性产生了构型依赖性差异效应,产生了一种强效的μ选择性μ激动剂(D-Tic2类似物),其在小鼠输精管试验中的内在活性增加,以及一种强效的δ选择性δ拮抗剂(L-Tic2类似物)。这些结果表明,在肽中施加构象限制不仅可能改变受体选择性,还可能降低、完全消除甚至增强内在活性。四肽H-Tyr-Tic-Phe-Phe-NH2在豚鼠回肠试验中是一种中等效力的完全激动剂,因此代表一种具有混合μ激动剂/δ拮抗剂特性的化合物。具有游离C末端羧基的相应肽H-Tyr-Tic-Phe-Phe-OH显示出高δ受体亲和力(Kiδ = 1.2 nM)、前所未有的δ选择性(Kiμ/Kiδ = 1410)、作为δ拮抗剂的高效力(在小鼠输精管试验中对各种δ激动剂的Ke = 3 - 8 nM),并且与其他δ拮抗剂不同,没有μ拮抗剂特性。三肽H-Tyr-Tic-Phe-OH和H-Tyr-Tic-Phe-NH2也是δ拮抗剂。